{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05485974",
            "orgStudyIdInfo": {
                "id": "HBI-2438-101"
            },
            "organization": {
                "fullName": "HUYABIO International, LLC.",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Dose Escalation Study of HBI-2438 in Patients With Solid Tumors Harboring KRAS G12C Mutation",
            "officialTitle": "A Phase 1, Open Label, Dose Escalation of HBI-2438 in Patients With Advanced Malignant Solid Tumors Harboring KRAS G12C Mutation",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "a-dose-escalation-study-of-hbi-in-patients-with-solid-tumors-harboring-kras-mutation"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-09",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2022-08-01",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-08",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-08",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2022-08-01",
            "studyFirstSubmitQcDate": "2022-08-02",
            "studyFirstPostDateStruct": {
                "date": "2022-08-03",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-09-12",
            "lastUpdatePostDateStruct": {
                "date": "2023-09-13",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "HUYABIO International, LLC.",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "A Phase 1 dose escalation study in patients with advanced solid tumors harboring KRAS G12C mutation to determine the maximum tolerated dose and recommended Phase II dose of HBI-2438 and characterize its pharmacokinetic profile.",
            "detailedDescription": "A Phase 1, Open-Label, Dose Escalation of HBI-2438 in Patients with Advanced Malignant Solid Tumors Harboring KRAS G12C Mutation. The primary and secondary objectives are:\n\n1. To determine the MTD and recommended Phase 2 dose (RP2D) of HBI-2438 as an oral monotherapy for advanced solid tumors harboring KRAS G12C mutation.\n2. To characterize the PK of HBI-2438 in subjects with advanced malignant solid tumors harboring KRAS G12C mutation.\n\nHBI-2438 is an orally administered KRAS G12C Inhibitor and will be dosed once daily throughout the escalation and expansion phase. Up to 44 subjects will be enrolled sequentially into the 3+3 dose escalation and monitored throughout the study for safety and tolerability. The dose escalation phase will consist of 6 cohorts, with doses ranging from 150 to 1200mg. Once the MTD of RP2D is established, an additional 6-8 subjects with brain metastases will be enrolled into the expansion phase at that dose level."
        },
        "conditionsModule": {
            "conditions": [
                "Lung Cancer",
                "Non Small Cell Lung Cancer",
                "Colorectal Cancer",
                "Cancer of Pancreas",
                "Colon Cancer",
                "Solid Tumor",
                "Cancer"
            ],
            "keywords": [
                "KRAS G12C",
                "FIH"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SEQUENTIAL",
                "interventionModelDescription": "3+3 Dose Escalation Design with Expansion",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 44,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Dose Escalation and Expansion",
                    "type": "EXPERIMENTAL",
                    "description": "HBI-2438 will be given orally in ascending doses (escalation cohort), until the maximum tolerated dose or recommended Phase 2 dose is reached. Up to 6-8 patients will then be enrolled in the expansion cohort at the recommended dose.",
                    "interventionNames": [
                        "Drug: HBI-2438"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "HBI-2438",
                    "description": "KRAS G12C Inhibitor",
                    "armGroupLabels": [
                        "Dose Escalation and Expansion"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "To determine the maximum tolerated dose (MTD)",
                    "description": "Safety endpoints: Incidence of dose-limiting toxicities (DLTs)",
                    "timeFrame": "Up to 36 months"
                },
                {
                    "measure": "adverse events (AEs), and serious adverse events (SAEs) overall",
                    "description": "Safety endpoints: adverse events (AEs), and serious adverse events (SAEs) overall",
                    "timeFrame": "Up to 36 months"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "maximum plasma concentration (Cmax)",
                    "description": "Pharmacokinetic variables including maximum plasma concentration (Cmax)",
                    "timeFrame": "Cycle 1 (21 days)"
                },
                {
                    "measure": "minimum plasma concentration (Cmin)",
                    "description": "Pharmacokinetic variables including minimum plasma concentration (Cmin)",
                    "timeFrame": "Cycle 1 (21 days)"
                },
                {
                    "measure": "Area Under the Curve (AUC)",
                    "description": "Pharmacokinetic variables including Area Under the Curve (AUC)",
                    "timeFrame": "Cycle 1 (21 days)"
                },
                {
                    "measure": "Pharmacokinetic variables including clearance",
                    "description": "Pharmacokinetic variables including clearance",
                    "timeFrame": "Cycle 1 (21 days)"
                },
                {
                    "measure": "Pharmacokinetic variables including serum half-life",
                    "description": "Pharmacokinetic variables including serum half-life",
                    "timeFrame": "Cycle 1 (21 days)"
                },
                {
                    "measure": "Pharmacokinetic variables including volume of distribution",
                    "description": "Pharmacokinetic variables including volume of distribution",
                    "timeFrame": "Cycle 1 (21 days)"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\nKey Inclusion Criteria:\n\nMale or female at least 18 years of age at the time of signing the ICF prior to initiation of any study specific activities/procedures\n\nAdvanced malignant solid tumors with KRAS G12C mutation- as determined by genetic testing\n\nMust have failed or refused standard of care therapy, are not eligible for standard of care therapy, or cannot benefit from standard of care therapy, in the opinion of the Investigator\n\nAt least 1 measurable target lesion that meets the definition of RECIST v1.1\n\nECOG Performance Status of 0 or 1\n\nDemonstrate adequate organ function\n\nExpected survival time \\> 3 months in the opinion of the investigator\n\nMust be able to swallow oral medications and must not have gastrointestinal abnormalities that significantly affect drug absorption\n\nExclusion Criteria:\n\nKey Exclusion Criteria:\n\nHistory of another concurrent malignancy within 3 years prior to study entry, unless the malignancy was treated with curative intent and the likelihood of relapse is \\<5% in 2 years Note: Subjects with a history of squamous or basal cell carcinoma of the skin or carcinoma in the situ of the cervix may be enrolled\n\nUntreated or symptomatic central nervous system (CNS) metastases Note: Subjects with asymptomatic treated CNS metastases are eligible provided they have been clinically stable and not requiring steroids for at least 4 weeks\n\nClinically significant cardiovascular disease, including stroke or myocardial infarction within 6 months prior to first dose of HBI-2438; or the presence of unstable angina or congestive heart failure of New York Heart Association Grade 2 or higher\n\nAny unresolved Grade 2 or greater toxicity from previous anti-cancer therapy, except alopecia, within 4 weeks of first study treatment administration\n\nActive autoimmune diseases or history of autoimmune diseases that may relapse\n\nPregnant or nursing\n\nPrior treatment with any KRAS G12C inhibitors\n\nAny condition that required systemic treatment with either corticosteroids (\\>10 mg daily of prednisone or equivalent) or other immunosuppressive medication \u226414 days before the first study treatment administration\n\nTreatment with other investigational drugs/devices within 4 weeks prior to first study treatment administration",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "John Ning, MD,PhD,FAIC",
                    "role": "CONTACT",
                    "phone": "858-280-1866",
                    "email": "jning@huyabio.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Alberto Bessudo, MD",
                    "affiliation": "California Cancer Associates for Research and Excellence, Inc. (cCare)",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "California Cancer Associates for Research and Excellence, Inc. (cCare)",
                    "status": "RECRUITING",
                    "city": "Encinitas",
                    "state": "California",
                    "zip": "92024",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Christina Spencer",
                            "role": "CONTACT",
                            "phone": "760-452-3909",
                            "email": "cspencer@ccare.com"
                        },
                        {
                            "name": "Alberto Bessudo, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.03699,
                        "lon": -117.29198
                    }
                },
                {
                    "facility": "The Oncology Institute of Hope and Innovation",
                    "status": "RECRUITING",
                    "city": "Glendale",
                    "state": "California",
                    "zip": "91204",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Leslie Posadas",
                            "role": "CONTACT",
                            "phone": "562-693-4477",
                            "email": "lposadas@icrinstitute.com"
                        },
                        {
                            "name": "Amitabha Mazumder, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.14251,
                        "lon": -118.25508
                    }
                },
                {
                    "facility": "The Oncology Institute of Hope and Innovation",
                    "status": "RECRUITING",
                    "city": "Long Beach",
                    "state": "California",
                    "zip": "90805",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Leslie Posadas",
                            "role": "CONTACT",
                            "phone": "562-693-4477",
                            "email": "lposadas@icrinstitute.com"
                        },
                        {
                            "name": "Amitabha Mazumder, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.76696,
                        "lon": -118.18923
                    }
                },
                {
                    "facility": "The Oncology Institute of Hope and Innovation",
                    "status": "RECRUITING",
                    "city": "Pasadena",
                    "state": "California",
                    "zip": "91105",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Leslie Posadas",
                            "role": "CONTACT",
                            "phone": "562-693-4477",
                            "email": "lposadas@icrinstitute.com"
                        },
                        {
                            "name": "Amitabha Mazumder, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.14778,
                        "lon": -118.14452
                    }
                },
                {
                    "facility": "California Cancer Associates for Research and Excellence, Inc. (cCare)",
                    "status": "RECRUITING",
                    "city": "San Marcos",
                    "state": "California",
                    "zip": "92069",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Christina Spencer",
                            "role": "CONTACT",
                            "phone": "760-452-3909",
                            "email": "cspencer@ccare.com"
                        },
                        {
                            "name": "Alberto Bessudo, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.14337,
                        "lon": -117.16614
                    }
                },
                {
                    "facility": "The Oncology Institute of Hope and Innovation",
                    "status": "RECRUITING",
                    "city": "Santa Ana",
                    "state": "California",
                    "zip": "92705",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Leslie Posadas",
                            "role": "CONTACT",
                            "phone": "562-693-4477",
                            "email": "lposadas@icrinstitute.com"
                        },
                        {
                            "name": "Amitabha Mazumder, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.74557,
                        "lon": -117.86783
                    }
                },
                {
                    "facility": "Sarcoma Oncology",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Santa Monica",
                    "state": "California",
                    "zip": "90403",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Victoria S Chua-Alcala, MD, CLS",
                            "role": "CONTACT",
                            "phone": "310-552-9999",
                            "email": "vchua@sarcomaoncology.com"
                        },
                        {
                            "name": "Sant Chawla, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.01945,
                        "lon": -118.49119
                    }
                },
                {
                    "facility": "Innovative Clinical Research Institute (ICRI)",
                    "status": "RECRUITING",
                    "city": "Whittier",
                    "state": "California",
                    "zip": "90603",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Leslie Posadas",
                            "role": "CONTACT",
                            "phone": "562-693-4477",
                            "email": "lposadas@icrinstitute.com"
                        },
                        {
                            "name": "Amitabha Mazumder, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.97918,
                        "lon": -118.03284
                    }
                },
                {
                    "facility": "The Oncology Institute of Hope and Innovation",
                    "status": "RECRUITING",
                    "city": "Whittier",
                    "state": "California",
                    "zip": "90603",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Leslie Posadas",
                            "role": "CONTACT",
                            "phone": "562-693-4477",
                            "email": "lposadas@icrinstitute.com"
                        },
                        {
                            "name": "Amitabha Mazumder, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.97918,
                        "lon": -118.03284
                    }
                },
                {
                    "facility": "BRCR Medical Center",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Plantation",
                    "state": "Florida",
                    "zip": "33322",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Ines Padron",
                            "role": "CONTACT",
                            "phone": "561-447-0614",
                            "phoneExt": "102",
                            "email": "ipadron@brcrglobal.com"
                        },
                        {
                            "name": "Harshad Amin, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 26.13421,
                        "lon": -80.23184
                    }
                },
                {
                    "facility": "Michigan Center of Medical Research",
                    "status": "RECRUITING",
                    "city": "Farmington Hills",
                    "state": "Michigan",
                    "zip": "48334",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Rameez Umer",
                            "role": "CONTACT",
                            "phone": "248-747-4383",
                            "email": "rameez.umer@michmer.com"
                        },
                        {
                            "name": "Richard P Zekman, DO",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.48531,
                        "lon": -83.37716
                    }
                },
                {
                    "facility": "Alliance for Multispecialty Research, LLC",
                    "status": "RECRUITING",
                    "city": "Kansas City",
                    "state": "Missouri",
                    "zip": "64114",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Jennifer Ross",
                            "role": "CONTACT",
                            "phone": "816-943-0770",
                            "email": "jennifer.ross@amrllc.com"
                        },
                        {
                            "name": "Jaswinder Singh, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.09973,
                        "lon": -94.57857
                    }
                },
                {
                    "facility": "Gabrail Cancer Center",
                    "status": "RECRUITING",
                    "city": "Canton",
                    "state": "Ohio",
                    "zip": "44718",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Kim Roby",
                            "role": "CONTACT",
                            "phone": "330-492-3345",
                            "phoneExt": "227",
                            "email": "kroby@gabrailcancercenter.com"
                        },
                        {
                            "name": "Nashat Gabrail, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.79895,
                        "lon": -81.37845
                    }
                },
                {
                    "facility": "Pan American Center for Oncology Trials (PanOncology Trials)",
                    "status": "RECRUITING",
                    "city": "Rio Piedras",
                    "zip": "00935",
                    "country": "Puerto Rico",
                    "contacts": [
                        {
                            "name": "Maria R Cruz-Correa, MD,PhD,AGAF,FASGE",
                            "role": "CONTACT",
                            "phone": "787-407-3333",
                            "email": "marcia.cruzcorrea@panoncologytrials.com"
                        },
                        {
                            "name": "Marcia R Cruz-Correa, MD,PhD,AGAF,FASGE",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 18.39745,
                        "lon": -66.04989
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000008175",
                    "term": "Lung Neoplasms"
                },
                {
                    "id": "D000010190",
                    "term": "Pancreatic Neoplasms"
                }
            ],
            "ancestors": [
                {
                    "id": "D000012142",
                    "term": "Respiratory Tract Neoplasms"
                },
                {
                    "id": "D000013899",
                    "term": "Thoracic Neoplasms"
                },
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000008171",
                    "term": "Lung Diseases"
                },
                {
                    "id": "D000012140",
                    "term": "Respiratory Tract Diseases"
                },
                {
                    "id": "D000004067",
                    "term": "Digestive System Neoplasms"
                },
                {
                    "id": "D000004066",
                    "term": "Digestive System Diseases"
                },
                {
                    "id": "D000004701",
                    "term": "Endocrine Gland Neoplasms"
                },
                {
                    "id": "D000010182",
                    "term": "Pancreatic Diseases"
                },
                {
                    "id": "D000004700",
                    "term": "Endocrine System Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M5546",
                    "name": "Carcinoma, Non-Small-Cell Lung",
                    "relevance": "LOW"
                },
                {
                    "id": "M13110",
                    "name": "Pancreatic Neoplasms",
                    "asFound": "Cancer of Pancreas",
                    "relevance": "HIGH"
                },
                {
                    "id": "M11172",
                    "name": "Lung Neoplasms",
                    "asFound": "Lung Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M14979",
                    "name": "Respiratory Tract Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M16658",
                    "name": "Thoracic Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M11168",
                    "name": "Lung Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14977",
                    "name": "Respiratory Tract Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M7256",
                    "name": "Digestive System Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M8886",
                    "name": "Gastrointestinal Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M7255",
                    "name": "Digestive System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8883",
                    "name": "Gastrointestinal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M7863",
                    "name": "Endocrine Gland Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M13102",
                    "name": "Pancreatic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M7862",
                    "name": "Endocrine System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T4387",
                    "name": "Pancreatic Cancer",
                    "asFound": "Cancer of Pancreas",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BC08",
                    "name": "Respiratory Tract (Lung and Bronchial) Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC06",
                    "name": "Digestive System Diseases"
                },
                {
                    "abbrev": "BC19",
                    "name": "Gland and Hormone Related Diseases"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        }
    },
    "hasResults": false
}